Clinical trials: ED
Erectile Dysfunction (ED)
Evaluation of the Rigicon Infla10® Inflatable Penile Prosthesis (IPP) for Erectile Dysfunction
This study evaluates the long-term safety and effectiveness of the Rigicon Infla10® Inflatable Penile Prosthesis in patients with erectile dysfunction.
- Trial name
- UNITED (NCT07273773)
- Testing
- Rigicon Infla10® Inflatable Penile Prosthesis (IPP)
- Where
- 4 sites in United States
- Volunteers
- 182 people
- Sponsor
- Rigicon, Inc.
Patients Presenting With Suspicion of Infection to the ED
Risk Stratification Using Midregional Proadrenomedullin in the ED
Emergency departments (ED) are becoming increasingly over-crowded, with patients facing prolonged waiting times. Therefore, a safe and rapid assessment that identifies patients with low severity that could be treated as…
- Trial name
- NCT05108883
- Testing
- MR-proADM KRYPTOR
- Where
- 9 sites in France, Italy and 2 more
- Volunteers
- 463 people
- Sponsor
- Brahms AG
Patients Presenting With Suspicion of Infection to the ED
Identifying Patients With Suspicion of Infection in the ED Who Have Low Disease Severity Using MR-proADM - Pilot Study
Emergency departments (ED) are becoming increasingly over-crowded, with patients facing prolonged waiting times. Therefore, a safe and rapid assessment that identifies patients with low severity that could be treated as…
- Trial name
- IDEAL (NCT03770533)
- Testing
- MR-proADM guided
- Where
- 4 sites in Spain
- Volunteers
- 200 people
- Sponsor
- Brahms AG
Erectile Dysfunction (ED)
Sano V First In Human Study to Treat ED
A Prospective, First in Human Study to Evaluate the Safety and Performance of a Flow Modification System
- Trial name
- FMS (NCT03651024)
- Testing
- ED surgery
- Volunteers
- 10 people
- Sponsor
- Sano V Pte Ltd
Erectile Dysfunction (ED)
Efficacy Study of RX-10100 to Treat Erectile Dysfunction (ED)
The primary objective of this Phase IIa trial is to determine the effective doses and treatment period for an upcoming RX-10100 Phase IIb trial in subjects with erectile dysfunction (ED).
- Trial name
- NCT00693056
- Testing
- RX-10100 5mg, RX-10100 10mg, RX-10100 15mg
- Where
- 3 sites in United States
- Volunteers
- 40 people
- Sponsor
- Rexahn Pharmaceuticals, Inc.